MK-0429
CAS No. 227963-15-7
MK-0429 ( MK0429 )
Catalog No. M13624 CAS No. 227963-15-7
MK-0429 is a potent, selective, orally-active nonpeptide αvβ3 integrin inhibitor with IC50 of 0.08 nM in SPAV3 assay.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
50MG | 1674 | Get Quote |
|
100MG | 2502 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMK-0429
-
NoteResearch use only, not for human use.
-
Brief DescriptionMK-0429 is a potent, selective, orally-active nonpeptide αvβ3 integrin inhibitor with IC50 of 0.08 nM in SPAV3 assay.
-
DescriptionMK-0429 is a potent, selective, orally-active nonpeptide αvβ3 integrin inhibitor with IC50 of 0.08 nM in SPAV3 assay; displays approximately 100-fold selectivity for αvβ3 over αvβ5 (IC50=10 nM), and no significant activity for the fibrinogen receptor αIIBβ3 (IC50>30 uM); shows activity in different animal models of bone turnover and has potentiation for the prevention and treatment of osteoporosis; also reduces melanoma metastasis both in vitro and in vivo.Prostate Cancer Phase 1 Discontinued
-
SynonymsMK0429
-
PathwayCell Cycle/DNA Damage
-
TargetIntegrin
-
RecptorIntegrin
-
Research AreaCancer
-
IndicationProstate Cancer
Chemical Information
-
CAS Number227963-15-7
-
Formula Weight439.51
-
Molecular FormulaC23H29N5O4
-
Purity>98% (HPLC)
-
SolubilityDMSO : 250 mg/mL 568.82 mM
-
SMILESO=C(O)C[C@@H](C1=CC=C(OC)N=C1)N2CCN(CCCC3=NC4=C(CCCN4)C=C3)C2=O
-
Chemical Name(S)-3-(6-methoxypyridin-3-yl)-3-(2-oxo-3-(3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl)imidazolidin-1-yl)propanoic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Hutchinson JH, et al. J Med Chem. 2003 Oct 23;46(22):4790-8.
2. Pickarski M, et al. Oncol Rep. 2015 Jun;33(6):2737-45.
3. Zhou X, et al. Pharmacol Res Perspect. 2017 Oct;5(5).
2. Pickarski M, et al. Oncol Rep. 2015 Jun;33(6):2737-45.
3. Zhou X, et al. Pharmacol Res Perspect. 2017 Oct;5(5).
molnova catalog
related products
-
Arg-Gly-Asp TFA
RGD Trifluoroacetate is a tripeptide that effectively triggers cell adhesion addresses certain cell lines and elicits specific cell responses; binds to?integrins.
-
Tirofiban hydrochlor...
A potent, selective inhibitor of the platelet fibrinogen receptor GPIIb/IIIa with IC50 of 9 nM.
-
Vedolizumab
Vedolizumab is a humanized monoclonal antibody that targets the α4β7 integrin for the treatment of ulcerative colitis and Crohn's disease.